Manulife Financial Corporation (MFC) Earnings Call Transcript & Summary
November 5, 2026
Earnings Call Speaker Segments
Hung Ko
executiveThanks, and welcome to Manulife's conference call on earnings, where we'll go over the financial and operating results for our third quarter of 2026. You can find our earnings materials, which include the webcast slides for today, in the Investor Relations section of our site, manulife.com. First, though, please see Slide 2 for a caution regarding forward-looking statements, and Slide 34 for a note about the non-GAAP and other financial measures that this presentation uses. Keep in mind that certain material factors or assumptions go into making forward-looking statements, and what actually happens could differ materially from what is stated. Moving to Slide 4. We'll kick off today's presentation with Phil Witherington, our President and Chief Executive Officer, who will give a highlight of our third quarter 2023 results as well as a strategic update. After Phil, Colin Simpson, our Chief Financial Officer, will go through the company's financial and operating results in greater detail. Once their prepared remarks are done, we'll move to the live Q&A portion of the call. With that, I'd like to hand the call over to Phil.
Philip Witherington
executiveThanks, Hung, and I’m glad everyone could join us. Before we begin, I’d like to take a moment to remember our good friend and colleague Stephanie Fadous, whose passing in September came as a shock to us all. Stephanie was a remarkable leader whom our team held in the highest regard. Several of you worked closely with Stephanie. Over a career spanning more than 2 decades at Manulife, her contributions were numerous and she made a permanent impression on this company. The warmth, insight, good judgment, and compassion she extended to those around her will be greatly missed. Our thoughts stay with Stephanie’s family and friends, and everyone at Manulife offers them our full support. Before we get into today's agenda, I'd like to recognize Sinead O'Connor, who joins us on this call and was recently appointed Chief Actuary. Having her as the latest addition to our executive leadership team makes me extraordinarily proud. Sinead comes to us with deep experience and a leadership record that speaks for itself, and I have every confidence she will carry forward the strength and momentum of our actuarial in-force and reinsurance operations and the highly talented people working in them. With that, I'll begin with a look at how we performed financially in the third quarter, starting on Slide 6; the quarter brought strong results, which show the strength and advantages of our diversified global portfolio. On the insurance side, new business results held up well and came in roughly matching the strong figures from a year earlier. APE sales in Asia stayed solid, with Hong Kong and Japan each posting growth of about 40% versus last year, though this was partly offset by weaker sales in the Chinese Mainland. Individual insurance sales in Canada also grew strongly, driven by a sizable transaction in Affinity Markets along with ongoing momentum in participating life sales. Our top-line value metrics grew at a steady year-over-year pace, and our CSM balance rose 9%, which gives further support to future earnings generation. Within Global WAM, retirement drove $3.6 billion in net outflows; even so, retail showed a notable improvement, and our institutional business kept producing net flows, with meaningful contributions from Manulife Comvest. On profitability, we posted record core EPS, 6% higher year-over-year, supported by continued double-digit core earnings growth in Asia and meaningful contributions from our North American insurance businesses. Although the eMPF transition in Hong Kong weighed on core earnings in Global WAM, the overall results show the value of our global operating model. We posted a solid core ROE of 17.8% as well. Beyond that, adjusted book value per share rose 9% year over year, and we're still giving back a substantial amount of capital to shareholders. Last, managing our balance sheet actively matters, especially given today's macro backdrop. In the third quarter, we divested more than $1 billion in equities, and you'll see that reflected in our go-forward sensitivities. Let's move to Slide 7. A year ago, we introduced our refreshed enterprise strategy, built around our ambition to be the #1 choice for customers. Since then, we've acted fast and continued to deliver on our strategic priorities. Before I get to this quarter's strategic highlights, I'd like to emphasize a handful of what we've accomplished. Our greatest strengths are our winning team and culture, and we keep investing so colleagues have the right skills, tools and opportunities to drive long-term growth. That dedication to our people keeps getting confirmed from outside: Manulife regularly places in the top quartile for employee engagement within our industry, and we're recognized worldwide as a top place to work. During the last year, we've acted decisively to diversify our portfolio further and to keep positioning Manulife for high-quality, sustainable growth. Through a joint venture with Mahindra, we entered India's life insurance market. In Indonesia, we acquired Schroders, and we completed both the purchase and the integration of Comvest Credit Partners. As we work toward being the most trusted partner in health, wealth and financial well-being, this year has brought meaningful strides in expanding our wellness offerings and in making health care simpler to reach. Our Hong Kong medical specialist network is expanding through the partnership we started with Bupa, which gives customers convenient, affordable and personalized access to high-quality care; and we broadened access to cancer testing through 2 important initiatives — first, extending access for North American customers to the GRAIL Galleri multi-cancer early detection test; and second, an exclusive partnership with Guardant Health that offers the Shield Multi-Cancer Detection test to customers across multiple markets in Asia. Improving experiences, transforming process, creating greater competitive differentiation and delivering value all depend on becoming an AI-powered organization. Celent naming us a Model Insurer for how we apply AI in underwriting shows the real headway we've made bringing AI innovation throughout the company. With these capabilities continuing to scale, we're firmly positioned to reach and surpass the $1 billion in cumulative enterprise AI value we're targeting by 2027. Strengthening distribution is another way Manulife stands apart strategically. In the past year, for example, we extended our bancassurance relationship with Chinabank in the Philippines, and within Global WAM we teamed up with L&G, merging our complementary strengths and widening access to differentiated investment solutions for institutional, retirement and retail clients around the world. In the U.S., we expanded our wholesaling group to accelerate coverage of both high-net-worth and emerging high-net-worth segments. On Slide 8, we review third-quarter progress. In Canada, we enhanced the segregated fund offering and broadened availability of existing funds, which gives investors more options and flexibility while assisting them in diversifying holdings and building wealth over the long term. Within Global WAM, Manulife Comvest closed Comvest Credit Partners Fund VII at USD 5.4 billion, the biggest raise ever for Comvest, extending the platform's reach among investors worldwide. And here in the U.S., we grew our protection offerings by adding enhanced index universal life features plus further differentiated term life options, which gives financial professionals more flexibility to address changing customer needs. This quarter we also achieved substantial progress in scaling and advancing our AI capabilities. Our strategic partnership with Microsoft was broadened as we extended Copilot to over 30,000 colleagues and deployed Microsoft Agent 365 to boost productivity, back innovation and reinforce enterprise AI governance. Turning to Asia: we've introduced AI-powered advisory tools in the Chinese Mainland and Malaysia, helping agents evaluate what customers need, identify protection gaps, and offer more tailored service. And at Global WAM, we completed the launch of an AI-enabled adviser engagement platform across North America retail, which surfaces 4x more product opportunities, captures deeper adviser insights, and boosts productivity through automated documentation. Finally, through innovative partnerships we're reinforcing our leadership in health and longevity; in Asia, we're working with Ant Health to make health care easier for customers to reach. Our first joint effort with Ant Health launched in October, offering cashless direct billing through Alipay to eligible customers at participating health care providers in the Chinese Mainland. In Canada, we partnered with Sword to provide AI-powered virtual physiotherapy for eligible group benefits members, helping them recover faster and return to work sooner. All of these efforts combined demonstrate how dedicated we are to assisting customers in living longer, healthier lives with greater financial resilience. To wrap up, I'm happy with our performance during this quarter. What stands out in our results is the strength and resilience of our diversified global portfolio—especially given an uncertain operating environment—along with the significant progress we've made over the past year in executing our enterprise strategy. I'm enthusiastic about what lies ahead as we continue to make decisions easier and lives better for our customers, while also generating long-term value for our shareholders. With that, I'll turn it over to Colin to go through our quarterly results in more detail. Colin?
Colin Simpson
executiveAppreciate that, Phil, and morning to all of you. This quarter delivered solid numbers, backed by the strength of our worldwide business. Our annual actuarial assumption review—what we call the basis change—also wraps up in Q3, and it produced a net favorable result while boosting our assurance that reserves are on a firm footing. Slide 23 in the appendix lays out further specifics. Ahead of taking your questions, I'll walk you through how we performed financially. Beginning with top line results on Slide 10: our new business metrics were roughly consistent with the same period a year ago. Following up on what Phil said, we recorded robust APE sales gains across Hong Kong, Japan, and Canada's individual insurance segment, which were partially counterbalanced by items I'll address shortly. Within Global WAM, although flows were better than the previous year, retirement drove net outflows totaling $3.6 billion. Now looking at Slide 11 regarding core earnings: our core net insurance service result increased compared with a year earlier, thanks to sustained healthy business expansion in Asia and the U.S., beneficial claims outcomes in U.S. Life and Canadian individual insurance, plus the net positive effect of the basis change—though this was partly counterbalanced by adverse U.S. Life lapse experience and Canada Group insurance claims results. Continuing, our core net investment result declined versus the previous year, largely because ECL provisions increased—consistent with our medium-term guidance, though the prior year had a release. Finally, Global WAM pretax earnings came in roughly flat against the prior year, as greater net fee income driven by AUM growth over the last 12 months plus contributions from the Comvest acquisition outweighed the eMPF transition impact in Hong Kong. Turning to Slide 12, core EPS rose 6% year-over-year, driven by 4% growth in core earnings along with the benefits of ongoing share buybacks. For the quarter, net income was $1.4 billion. That figure reflects ALDA returns that were better than the prior period but still below what we had anticipated, along with public equity results that fell short of expectations and losses tied to derivatives and to hedge accounting ineffectiveness. The ALDA charges stemmed primarily from private equity, real estate, and farmland investments. Seeing improvement on a sequential basis was encouraging, but in the near term the present environment will probably keep pressuring ALDA returns. You will also see that we have added supplemental detail about our ALDA portfolio in the appendix of today's presentation, which should help you understand why our expected long-term returns of 9% to 9.5% remain appropriate. Net income took a hit from two other things as well: the basis change, plus a write-down on an acquired intangible tied to a Vietnam distribution deal signed back in 2021 — before the market ran into trouble and then shrank. Now let's turn to how each segment performed, beginning with Asia on Slide 13. APE sales were about level with the prior year. A 45% increase in Hong Kong and a 39% rise in Japan year over year were offset by softer sales in the Chinese Mainland. Inside the Chinese Mainland, the decline reflected lower sales of participating savings products set against a strong result twelve months earlier — a pattern we're seeing across the industry. Meanwhile, Hong Kong's robust sales mirror stronger demand for savings products among global high net worth clients. Our value metrics were roughly consistent with the same quarter last year, since growth in Hong Kong and Japan was outweighed by declines in the Chinese Mainland and Singapore. Core earnings across Asia remained solid, rising 17% versus the comparable quarter a year ago, mostly powered by ongoing business expansion plus a handful of smaller items, among them this year's basis change. That was partly offset by greater ECL provisions. Turning now to Global WAM, Slide 14. Net flows faced persistent headwinds again this quarter, chiefly within our retirement business. In U.S. Retirement, net outflows stemmed mainly from elevated planned sponsor redemptions, whereas net outflows in Canadian retirement were modest and mirrored weaker new plan sales. We additionally recorded net member withdrawals tied to larger account balances generated by market appreciation throughout North America; this was partly offset by net inflows in our institutional channel, powered by ongoing momentum at Manulife Comvest. Retail flows were essentially flat this quarter, as strength in Canada Wealth and Asia retail helped counter outflows via third-party intermediaries in North America. Core earnings fell 5% versus a year earlier, as greater net fee income from favorable market impacts across the past 12 months plus contributions from the Manulife Comvest business were outweighed by the eMPF transition's impact in Hong Kong, elevated workforce-related expenses, investment in business growth, the absence of favorable tax true-ups recorded a year ago, and reduced performance fees. Now to Canada, Slide 15. This quarter, APE sales rose 3% year-over-year, driven by greater individual insurance sales, including a sizable affinity market sale, plus higher participating life sales, partly offset by weaker group insurance sales. Robust individual insurance sales, together with better annuity margins, produced 5% growth in new business CSM, though weaker individual insurance margins partly offset that. Core earnings rose slightly—up 3% from the prior year—reflecting better claims results in individual insurance, improved Manulife Bank earnings, and broader investment spreads, though those gains were partly counterbalanced by weaker claims in Group Insurance and higher ECL provisions. Even though insurance experience overall came in positive this quarter, group benefits remained strained, despite claims showing a slight improvement from the previous quarter. Now let's turn to the U.S. segment results on Slide 16. APE sales were on par with the strong quarter last year, but product mix changes led to lower value metrics. Underlying earnings rose 5% from the prior year, driven by better life insurance claims results, which included net favorable effects from this year's basis change, along with business expansion and beneficial tax items. These gains were partly offset by higher ECL provisions and adverse lapse experience. Turning to Slide 17. Adjusted book value per share keeps climbing, up 9% compared with a year earlier to $41.78. We achieved that while giving back $5.3 billion of capital to shareholders during the last 12 months. Let's now look at the balance sheet on Slide 18. Our capital position remains solid, with a LICAT ratio of 136%, which works out to $25 billion above the supervisory target ratio. At 23%, our financial leverage ratio sits well under our medium-term target of 25%. These figures highlight how strong our balance sheet and capital position are, giving us considerable financial flexibility and underpinning our capacity to keep delivering long-term growth. Finally, Slide 19 sets out how we performed against our 2027 and medium-term targets. We're happy with the momentum built this quarter toward our financial objectives, with Asia leading the way through strong results. Core ROE came in at 17.8%, showing continued movement toward our 18% plus target. There's still work ahead to reach that goal, but the progress made this year encourages us; that wraps up our prepared remarks. Before we begin the Q&A session, I'd like to remind everyone to stick to a limit of 2 questions, follow-ups included, and to requeue if they have more questions. Operator, we'll now open the call for questions.
John Aiken
analystIt was encouraging to see such robust demand in Hong Kong balancing out Mainland China, though I have to admit I was somewhat taken aback that Singapore showed a bit less growth. Could you explain what's behind the demand dynamics when comparing Hong Kong with Singapore?
Steven Finch
executiveAbsolutely, John, and thanks for raising that. Yes, we felt good about the growth you mentioned in Hong Kong, where every one of our new business metrics rose by double digits. The largest contributor to that growth, as we observed, came from the high net worth segment. In that space, Manulife holds the leading position. Demand from global customers in Hong Kong has been extremely robust. So that represented the primary catalyst for the quarter in Hong Kong. Over in Singapore, we have a top-tier franchise, with leadership standing across channels. And we — looking at year-to-date figures, I think if you examine a longer timeframe, year-to-date, we've delivered solid double-digit growth. I'd attribute Q3 to ordinary fluctuation; our confidence remains intact as we look ahead in Singapore, including within the high net worth segment too. Singapore ranks among the foremost international financial hubs, and we are witnessing that expansion there as well.
Analyst
analystThank you, Steven. Since I have you, let me ask a second question as a follow-up. Regarding how things are going in Japan, how sustainable do we believe that is? And broadly speaking, what's the outlook for that region?
Steven Finch
executiveYes, thank you, John. So Japan, as you're aware, kept up its strong growth. Much like in earlier quarters, the main driver has been a supportive macro backdrop, with interest rates higher. We've been broadening our product propositions so we can serve a wider range of customers. And that has resonated. We've seen robust growth across channels. Macro factors do play a part in supporting the new business results, and that has been the case over the past few quarters. Still, the underlying growth is strong. We'd anticipate some normalization in the results as macro conditions normalize, but we continue to hold a favorable outlook for meeting the demands in Japan.
Gabriel Dechaine
analystI'll continue on that Asia sales point; and yes, Hong Kong sales did rise, and you explained what kinds of products we're selling there. But if I — this is my first NBV margin question, I believe. Yet your margin has fallen to below 40. A year ago, you were in the 50s. So the mix is less profitable. And I take it that's because you're selling more of this offshore high net worth business and less of the Mainland Chinese visitor business; so do you see an outlook for that more profitable mix to bounce back at any point soon?
Steven Finch
executiveYes. Thanks for the question, Gabe. As we noted, the high net worth proposition has resonated and we're seeing strong sales there. And the product customers choose in that space is the savings-oriented product. And it's a competitive space. It carries somewhat lower margins. To be clear, we're happy with the margins on the product, right? We're driving absolute dollars of value creation, whether it's NBCSM or NBV. And we do expect this business to be accretive to the company's ROE target of 18% plus. So that's really what drives the margin down that we're seeing, but we're pleased with the results. And looking forward, our focus is we've got a very diversified business in Hong Kong. We're focused on meeting the customer needs. And we'll meet those customer needs and drive value — to drive the value metrics; it's less about a focus on higher margin. It's more about meeting the customer need and generating value.
Gabriel Dechaine
analystAll right. Let me turn to the actuarial review. And I suppose I have a question for Sinead. On slide 23, top left, just to confirm that when the total impact shows up as a negative number, that's a favorable thing. And I'd like to dig into the mortality piece of it, which is a negative number, so also favorable, but it's fairly small as well; that might be the net outcome of some big moving parts. I'm just — curious whether there were any material adjustments to CSM or anything along those lines tied to the U.S. life block; not this quarter, but during earlier quarters that block has been producing some meaningful mortality losses, such that going forward, that experience should even out rather?
Sinéad O'Connor
executiveJohn, thanks for the question. This is Sinead speaking.
Gabriel Dechaine
analystGabriel.
Sinéad O'Connor
executiveGabriel, I'm sorry.
Gabriel Dechaine
analystJohn, you were the previous one to speak.
Sinéad O'Connor
executiveMy apologies. Well, this isn't the smoothest beginning, is it? As you mentioned, we did finish our yearly look at methods and assumptions during this quarter; and you're correct about that top-left figure, $128 million. On the whole, we recorded a decrease in fulfillment cash flows of $128 million; which means lower reserves; and regarding what you asked about mortality broadly, I'd say the $75 million represents the net effect. We examined a few items within that. We examined mortality and morbidity in Vietnam. And then we also examined U.S. mortality. But broadly speaking, I'd characterize the changes to both as fairly modest. And in the U.S., we have — we operate in the large case market, and we do see some claims variability. We've noted that recent experience has been shaped by a small number of large cases. And our review took into account all recent experience; we incorporated that. Once more, a modest reserve increase there. Given how we record our basis changes, our assumptions, it takes effect on July 1. So beginning in Q3, we did observe a slight improvement in the U.S. on experience. But even after accounting for that, I'd say our U.S. mortality experience this quarter came in positive, and we're now positive on a year-to-date basis.
Doug Young
analystI think this one's for you too, Sinead. Perhaps we could stay on that same slide. From what I saw, the actuarial assumption review included a charge tied to lapses, which makes sense to me; however, it also seems there was negative lapse experience during the quarter tied to the U.S. So I'm simply attempting to square that — I can only see the broader picture — but I'm attempting to square why negative lapse experience would keep showing up when you booked a lapse-related charge in your yearly actuarial assumption assessment, and I'm certain there's solid reasoning for it. Then also, what are you observing that's causing the adverse lapse experience, both within the ongoing P&L and in the actuarial review?
Sinéad O'Connor
executiveThanks, Doug. Sinead again here. This year's lapse review was in our Singapore block, actually. So we conducted U.S. lapse work in 2024. That was the most recent occasion we ran a review. And through this quarter, I'd have described us as neutral on average where lapse experience is concerned. This quarter, though, we did encounter some adverse lapse experience within our U.S. life block, but I'd view that as simply normal variability and definitely not something we regard as a trend. So that's essentially the explanation.
Doug Young
analystAll right. So regarding that negative lapse experience in the life block, which product was it tied to?
Sinéad O'Connor
executiveThat relates to our U.S. life business, and it's a minor — it's really — something we'd view as ordinary fluctuation.
Doug Young
analystOkay. So then, Steve, perhaps you could return to your own situation in Asia. I mean, APE sales came in flat, and new business value was flat too. The contribution to CSM from new business rose, I believe, 2% year-over-year during the quarter. So I suppose some people might question the growth outlook here. And I just wanted to hear your thoughts on how you'd sort of counter that. Obviously, I think core earnings for Asia were up 17% year-over-year. Just trying to get a sense of whether that's sustainable. What — why shouldn't we worry that a number of those metrics are flat when it comes to what will drive your bottom line growth going forward?
Steven Finch
executiveYes, Doug, thanks for asking. As you know, we're glad to see core earnings grow 17%, extending some strong growth that we've had this year. I'd note that growth in CSM Europe year-over-year is also up 10%, which signals future earnings. On the sales side, Colin covered it in his opening, but just to recap quickly, we saw growth in Hong Kong and Japan, very strong growth. It was offset during the quarter by a decline in the Chinese Mainland; and that was a trend we saw across the industry. There had effectively been an acceleration of sales in Q3 of the prior year that created a very tough comparable. So looking ahead, certainly in China, expect a materially stronger Q4 than in Q3; and while sales can vary quarter-to-quarter, and we would expect that, one of the nice features of IFRS-17 is that it doesn't result in core earnings variability. And as we look to the future across Asia, we remain optimistic about the prospects for growth and Manulife's multichannel distribution, multi-market presence, and we expect to continue capturing that growth looking forward.
Doug Young
analystSo you don't sense that anything is really getting in the way of your ability to grow the way you've done before — you don't believe that's the case...
Steven Finch
executiveRight. When we look ahead, we do see growth, and yes, I'd say we should expect the usual ups and downs. Hong Kong has been so strong for us. It's reasonable to anticipate some near-term fluctuation, but we see beyond that and face the future with confidence.
Tom MacKinnon
analystTwo things. First, regarding the Canadian Group LTD results. You mentioned a modest quarter-over-quarter improvement. How are things progressing on that — I believe your expectation is that it could be neutral by year-end? Just how you're tracking toward that pricing environment, and maybe any other color?
Patrick David Graham
executiveTom, Patrick here. Thanks for the question. So yes, we had a solid quarter overall on policyholder experience, with a gain of $15 million for the Canadian segment. That was mostly driven by positive experience in individual insurance, which we see as normal quarter-to-quarter variability. That was offset by continued morbidity pressure in group. We've kept seeing sequential improvement quarter over quarter, supported by the investments we've been making, and we remain optimistic that overall policyholder experience is trending toward neutral for year-end. On the pricing environment, for the second part of your question, the market is still competitive; we remain disciplined on pricing and take a very responsible and disciplined approach to pricing new business.
Tom MacKinnon
analystMy second question is likely directed at Steve Finch regarding Hong Kong. The MCV (sic) CMV segment has certainly generated plenty of headlines across the summer months and on into autumn. I believe you said that accounts for 25% of your Hong Kong sales. Could you — is there any color on what you've observed since the noted crackdown, so to speak, by the regulator when it comes to taxing these policies? What is your distribution network telling you about how this could be rolled out? And any color regarding additional regulatory shifts, perhaps regulating to some degree how much premium financing may be applied to these policies? So just a bit of an update on that.
Steven Finch
executiveThanks, Tom. Sure, I'll begin with the CMV business. And as you're aware, there have been various regulatory changes, I think all aimed at making this business more professional and more sustainable as we move forward; since last year we have observed a slowdown in CMV business while the market adjusts to some of these new regulations. Regarding the tax news you're referring to, I wouldn't describe it as a clamp down. This is — I see it as a signal to enforce existing tax rules; and what we're observing is, in the short term, slower decision-making, perhaps some pausing while people try to understand. And I think that's to be expected over the short term. I think really importantly, as we look ahead, there's a lot of conviction that this flow of wealth that has been occurring will continue. It's a structural trend that will persist as customers look to Hong Kong for products and services unavailable on the Mainland, currency diversification, a variety of different investments. So we expect this to remain an important part of our multichannel business going forward.
Philip Witherington
executiveAnd Tom, Phil here. Let me add just one thing to what Steve said: Hong Kong is coming forward with greater strength — not just as a financial hub for Greater China or Asia, but truly on a worldwide level. And more and more, as we examine where international and offshore business originates, the picture is far wider than the Chinese Mainland alone.
Tom MacKinnon
analystRight, and what about premium financing in terms of color? What portion of these policies would be premium financed? Is there any regulatory risk surrounding that?
Steven Finch
executiveYeah. So the regulator put out a circular essentially just clarifying what they expect, which I'd view as good practice regarding premium financing; financing is a common practice in the market within the high net worth space, though it also hinges on market conditions and how banks feel about their lending.
Tom MacKinnon
analystAnd what share of the policies you'd write would involve premium financing? Or is that — or is it difficult to say, since you may not know where the money is coming from?
Steven Finch
executiveThat shifts from quarter to quarter. In the past, it has formed a significant portion of the high net worth business. Still, there is a fair amount of fluctuation. The figures aren't at the top of my mind. As I mentioned, it fluctuates.
Tom MacKinnon
analystAll right, then. Now, I take it that this line of business carries substantial surrender penalties should any sort of lapse occur, so to speak?
Steven Finch
executiveThat's correct. Every risk inherent in those policies was examined and taken into account by us.
Bart Dziarski
analystA question about AI. We are seeing gains from AI, particularly in health care and in extending longevity. And looking at the retained long-term care block's active life reserves, it's relatively young at 74 years. So could you help us grasp that dynamic? Was that taken into account in your actuarial review this year? Or is it something we should be thinking about going forward?
Sinéad O'Connor
executiveBart, thanks for the question. I believe what you asked was, specifically, AI and advances in medical improvement...
Analyst
analystBetter longevity precisely—folks are simply living more years. That carries favorable health care advantages.
Sinéad O'Connor
executiveSo especially within our LTC business, what I'd say is we feel rather assured about how prudent our reserves are. And longevity, in particular, is a factor we've taken into account there. I'd add as well that these assumptions are long-term ones, and morbidity gets shaped by quite a few different elements. As a result, we can't necessarily know when or where the next medical breakthroughs will arrive. But broadly speaking, I believe that we — and we've demonstrated this via our reinsurance deals as of late — have shown the prudency of our reserves overall.
Philip Witherington
executiveAnd Bart, it's Phil here. I might add a few thoughts as well, and I'll turn it over to Brooks to speak directly about what's happening in the U.S. long-term care business. But 12 months ago, we pinpointed being AI-powered as a key strategic priority. And from that point on — actually even before, but from that point on — we've stepped up investment across a range of initiatives. Those initiatives span many areas of our operations, and there are plenty of examples we could take you through. Underwriting strikes me as a strong illustration of where we can capture gains not just from the cost reduction you might conventionally anticipate, but genuinely expand the business by serving customers faster, and we can enhance experience by achieving better-quality underwriting as a result. But when it comes to long-term care specifically, there are quite compelling use cases that we've already launched and that are producing concrete benefits. Brooks, over to you on that.
Brooks Tingle
executiveThanks, Phil, and thanks, Bart, for raising that. I'd say this is a genuinely significant macro-level question for the industry. It's amusing — every single day, somebody forwards me a piece claiming AI will bring about the end of humanity or something like that; and my reply is an article arguing AI will cure cancer and accomplish all these other things. And we're seeing enormous tailwinds for longevity over the long term. So what does that mean for our business? We aren't merely watching those trends. We're leaning into them and seeking to capitalize on them for the benefit of our customers and our shareholders; so life insurance is fairly obvious. For more than 10 years now, we've taken steps to engage our customers and offer them the latest innovations, which AI is simply going to accelerate to help them live longer, healthier, better lives; with LTC, in particular, we're taking a variation of that approach and engaging our existing LTC customers with tools, incentives, support programs to help them age in place. If you assume they will live longer, how do we keep them aging in place. Nobody wants — looks forward to the day they need assisted living facilities or services. So we're leaning in on this mega trend, I would say, and I think it will ultimately be a very positive tailwind for the industry.
Philip Witherington
executiveAnd just, you know, a quick stat on one part of the long-term care benefit that we've observed. On fraud reduction, our initiatives using AI capabilities have brought claims down by 6 percentage points. So our AI-powered strategy is producing quite tangible financial benefits.
Analyst
analystGreat. That's really useful context; and a follow-up, I suppose, perhaps directed at Colin — you mentioned financial flexibility, with a sizable amount available given leverage capacity plus excess capital. So how should we think about you putting that financial flexibility to work to generate growth?
Colin Simpson
executiveBart, thanks for asking. Look, this is a topic we devote a lot of time to discussing. We hold $10 billion above our operating limit, and that has to go toward a number of items. Organic uses rank #1 for our capital. So we're putting a lot into the business. You just heard Phil discuss AI. After that comes dividend and consistent dividend increases, and we have a solid record of stable and steady dividend increases, double digit actually as of late. And then — then we consider inorganic. We've completed Comvest. We acquired Schroders Indonesia, and we've been buying back shares on a consistent basis, and that has been supporting the core ROE. So it really helps that our balance sheet is so strong. We have this excess capital, but we also want to be judicious with it. And so that we hold a very high bar when it comes to things like inorganic, and we've witnessed the benefit of share buybacks; so nothing really new to discuss today, but it's just — we feel we're in a great place, and we want to capitalize on that.
Mehmed Rizvanovic
analystMy first question is for Colin. I'd like to revisit the ALDA portfolio. Thanks for giving us that extra disclosure. You mentioned there could be some additional headwinds in the near term. What I'm wondering is — I understand that over the long term, when the long end of the curve sits higher and rates are higher, ALDA is ultimately expected to recover. Could you perhaps offer some kind of timeline, or describe what environment would be conducive to ALDA returning to its historical performance?
Philip Witherington
executiveMike, thank you. This is Phil; we'll hand that one over to Trevor to answer.
Trevor Kreel
executiveMike, this is Trevor, and I appreciate the question. First off, just to give a bit of color on the quarter — clearly, we felt quite good about the better performance. The annualized return for the quarter came in at roughly 7.5%. That said, I think there are short-term geopolitical headwinds as well as interest rate headwinds, which obviously you read about in the papers every day, but there are also longer-term tailwinds, I think, given the impact of higher rates, market expectations, and I think some of the portfolio repositioning we have been doing over the last little while. My expectation is that if rates stay roughly at this level, there will be some near-term headwinds. There will be a decline in near-term ALDA valuations, perhaps for a couple of quarters, I would think. But then I think we would start to trend back toward our long-term assumptions. And I think higher rates are actually supportive of us trending back toward our long-term assumptions. Thanks for the question.
Mehmed Rizvanovic
analystOkay, thank you for those details. Then maybe for Phil — I'd like to ask, broadly speaking, about core versus reported. If you look at the pattern, or simply the cumulative difference since we adopted IFRS-17, it remains up in that high 20% area. And I'm just curious — I understand markets are constantly volatile. I understand interest rates have been volatile over recent years. But is there any kind of environment, whether macro or something particular to MFC, that could shrink that gap down the road? I'm just attempting to figure out how I ought to think about this gap that keeps showing up between core and reported.
Philip Witherington
executiveYes, Mike, it's Phil here, and thanks for that question. What we're seeing in the third quarter, I think, is a somewhat unusual quarter, because various items are contributing to what I'd call a bigger variance between core and net income than I'd normally expect. The one feature we've seen for quite a number of quarters now, and you addressed that in your earlier question, has been ALDA performance. Picking up on what Trevor said, we genuinely anticipate more of the same. If you look at 2026 as a whole, that gives you a fair sense of the kind of variability involved — what we've experienced this year is, I think, what you should expect over the coming quarters. That said, we're confident the long-term assumption is still the right one, and past the near term we'll gravitate toward it. I bring up the near term mainly because interest rates are elevated compared with where they sat a few years back. Regarding your question about what would be needed for net income to normalize or align with core earnings, I believe that's the single factor. It comes down to ALDA returning to our anticipated long-term assumptions of 9% to 9.5%. I genuinely consider that quite reasonable. And as Trevor mentioned, it aligns with a higher interest rate environment once the near-term effects of rates have worked their way through the system.
Mehmed Rizvanovic
analystAll right. So it would be reasonable to say that you see no structural cause for that gap to continue going forward. Essentially it comes down to ALDA plus markets behaving the way they do each quarter. Would that be accurate?
Philip Witherington
executiveThat seems accurate to me. What I'd point out, though, is that accounting contains certain asymmetries, in that gains get deferred to later periods while charges are recognized sooner. And that shows up. This quarter, the basis change for this year is a good illustration, since it's a net release of reserves, an overall positive, yet negative items wind up in net income while positive items remain in OCI and CSM and are amortized into the income statement over time. Still, I'd say your hypothesis is largely right. Nothing materially structural ought to produce a long-term disconnect between the 2.
Mario Mendonca
analystThere are many factors this quarter that push me toward accepting the 18% ROE target for 2027. One thing in particular pulls me the other way, and that's what I want to dig into today. In Global Wealth and Asset Management, net flow trends have clearly shifted over the past couple of years. Let's say last year. This business used to deliver positive flows consistently, and lately it hasn't. Is there anything you'd point to on Manulife's side — like how their funds are performing and what you're delivering to customers in that business? Or would you say it's entirely macro driven — markets have been strong, so retirement flows will be negative? That covers the first half of what I wanted to ask. Could you shed some light on why flows have weakened lately?
Paul Lorentz
executiveSure, happy to. Thanks, Mario — Paul speaking, and I'll field that. In response, my take is that it's likely a bit of both. Industry-wide pressures are certainly a factor. When retirement is concerned, robust markets are a drag on flows, though from an earnings standpoint they're a benefit. You've also witnessed some of the — simply the ups and downs when it comes to the active market in North America, along with this shift toward more ETF structures rather than funds. That, I'd argue, has been more of a phenomenon seen across the industry. On that front, our confidence in our resilience is fairly high. As Colin said, regarding our flows, there is considerable momentum beneath them. Gross flows came to $56 billion, up 16% versus the prior year; ETF gross was the second highest quarter on record, and ETF flows were very strong; and looking a bit further inside the business, at institutional, we've now been positive in 21 of the 22 quarters. Our retail business was flat, which reflects a trend that's improving and one we actually feel pretty good about when it comes to the retail outlook. On retirement, we did encounter some headwinds from planned redemptions in Canada and the U.S., though that kind of variability does come up from time to time. To put the franchise in perspective again: in Canada we're a top 2 player with 30% market share; in Hong Kong we're the leading player; and in the U.S. we're a top 5 player. We're in our core markets, which sit under $50 million, and we keep investing. So from an industry standpoint, we actually feel good about the underlying momentum. Last year we ran into some performance issues involving certain outside managers as well as a handful of in-house ones, and we've since largely corrected those. We also went through some personnel shifts, which does create a bit of disruption around the edges. Still, on the whole we're quite upbeat about what's ahead and feel confident about the business's underlying momentum going forward.
Philip Witherington
executiveMario, it's Phil here. If I may, I'd like to add one point, which is that we're putting money into GWAM with an eye on the future. We've discussed the Comvest investment as part of that effort, though that one is inorganic. As for organic investments, the structural commitments we've made to launch active ETFs are translating into positive flows — the gross flows Paul mentioned — along with the strong retail performance, and we'll keep investing. That's precisely why you've seen expenses in GWAM come in somewhat higher over the last few quarters.
Mario Mendonca
analystWell, expenses are actually what I was about to move on to, since this is a business and when you look at it across time, there's simply a long run of positive operating leverage — and really strong operating leverage at that. More lately, though, that has also gone negative or become much weaker. Regarding these investments in the business, how much longer do you think we'll see negative or weak operating leverage while you're investing? Does this last for a few more years, or is it a short-term matter?
Paul Lorentz
executiveYes. Thanks, Mario. I'd characterize it as more short-term. And bear in mind, when you look at expense growth, if you actually adjust for the Comvest and Schroders acquisitions, year-over-year expense growth is under 3% in the business, and those deals are contributing some earnings. I think what you've observed over the last year is that the transition to eMPF obviously affected the top line. But if you look at our core earnings year-over-year and adjust for the tax items, and look at core EBITDA, it's relatively flat year-over-year, and that absorbs the eMPF impact along with the acquisition. So think of it almost this way — we've been through the transition. We're basically where we were last year, and now we're well positioned for growth, and we're sitting at a margin of 29.6% in the quarter. So we would expect to keep seeing operating leverage from this point forward as we grow the business and continue managing expenses prudently.
Paul Holden
analystLet me keep this brief — I just want to follow up on what Mario asked regarding GWAM. If you look back at the Investor Day deck, GWAM was intended to be the number two driver of ROE improvement. That matters a lot when we consider the 18% goal for next year. Is there any sign that this is somewhat behind schedule compared with what you laid out at Investor Day, whether due to eMPF or genuinely higher expenses? Or would you tell us things are going to plan?
Paul Lorentz
executiveYes. Appreciate the question, Paul. This is Paul Lorentz speaking. From what we expected at Investor Day, we are on plan; and once more, bear in mind that we did factor in the shift to eMPF along with the targets we established. We put in place a set of targets covering ROE, margin, and the efficiency ratio as well. On margin, which I just mentioned, we are tracking well, and we sit within the efficiency ratio range. So we feel pretty good about the targets we laid out and about our record of hitting them next year.
Philip Witherington
executiveAnd Paul, it's Phil here. I believe your question also connects to the ROE topic. At Investor Day we set a target for ourselves of 18% plus ROE for 2027. And I do want to emphasize that, yes, there are obviously some challenges, and we've witnessed that through, for instance, what happened earlier this year in Canada; but as a leadership team, we have conviction in that 18% target, and we're working very hard to deliver it in 2027. And past 2027, our focus is on not just sustaining it, but scaling the business at that ROE; so I just want — don't want there to be any ambiguity that we continue working toward it.
Paul Holden
analystThat matters. And I want to wrap up with a last question about ALDA. Could you perhaps make the case for why 9% to 9.5% is the correct return? Perhaps you could give us a feel for the types of returns being underwritten on new investments?
Trevor Kreel
executivePaul, this is Trevor. Sure, as we've discussed previously, our ALDA portfolio consists of 6 different asset classes. Naturally, the underwritten returns for each one differ according to the specific space we're investing in. For asset classes like real estate, timber, and farmland, I'd say it's likely somewhat under that overall long-term target of 9%, 9.5%. When you look at infrastructure and private equity, I'd say it's somewhat above that. For both infrastructure and private equity, I'd point to roughly 12% to 15% as what we're observing in the market, and at times even higher; so with all of those asset classes combined in the overall portfolio, I think we stay comfortable that we'll get back to that long-term return of 9%, 9.5%.
Hung Ko
executiveThanks, operator. If any follow-up questions come up, we’ll be around after the call. Have a good day, everybody.
Operator
operatorThat concludes today's conference call. You're free to disconnect your lines now. Thanks for joining us, and enjoy the rest of your day.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Manulife Financial Corporation transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Manulife Financial Corporation earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Manulife Financial Corporation or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.